(Q57578932)

English

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer

No description defined

In more languages

edit

Statements

0 references

0 references

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer (English)

0 references

main subject

metastatic breast cancer

1 reference

Evandro de Azambuja

2

0 references

author name string

Lina Pugliano

series ordinal

1

0 references

publication date

2012

0 references

published in

Onkologie

0 references

volume

35

0 references

issue

9

0 references

page(s)

476-478

0 references

cites work

Extending survival with chemotherapy in metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

A unified definition of clinical anthracycline resistance breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000342209

retrieved

21 January 2018

Identifiers

DOI

10.1159/000342209

0 references

PubMed publication ID

23007143

0 references

(Q57578932)

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)